Torn Down

正Biking toward the village, where I should have seen nothing but rare Beijing darkness, I saw a gleaming new Holiday Inn-complete with valet park- ing and big, gaudy columns. It is a route I took every day in August 2008, to get to the Olympic wrestling     

Applicability of the ParaDNA® Screening System to Seminal Samples

Seminal fluid represents a common biological material recovered from sexual assault crime scenes. Such samples can be prescreened using different techniques to determine cell type and relative amount before submitting for full STR profiling. The ParaDNA^® Screening System is a novel forensic test which identifies the presence of DNA through amplification and detection of two common STR loci (D16S539 and TH01) and the Amelogenin marker. The detection of the Y allele in samples could provide a useful tool in the triage and submission of sexual assault samples by enforcement authorities. Male template material was detected on a range of common sexual assault evidence items including cotton pillow cases, condoms, swab heads and glass surfaces and shows a detection limit of 1 in 1000 dilution of neat semen. These data indicate this technology has the potential to be a useful tool for the detection of male donor DNA in sexual assault casework.     

Safe Haven Questioned: Proof of Identity Over Persecution of SOGIE Asylum Seekers and Refugee Claimants in Canada

Abstract

Canada, being a country that recognizes sexual orientation and gender identity/expression (SOGIE) as grounds for asylum or refugee status, can appear initially to be a safe haven for those persecuted based on such characteristics. Yet, claimants are required to prove the SOGIE upon which the persecution of the person is reported to have been based. Given that essentialist and binary notions of sexual orientation and gender identity/expression are the criteria utilized, such policy imposes traditional Westernized notions of identity with homonational and recolonizing effects on individuals who are attempting to resettle in Canada.     

Disability Rights Commission: From Civil Rights to Social Rights

This paper argues that, although originally conceived as part of the ‘civil rights’ agenda, the development of disability rights in Britain by the Disability Rights Commission (DRC) is better seen as a movement towards the realization of social, economic, and cultural rights, and so as reaffirmation of the indissolubility of human rights in the round. As such, that process of development represents a concrete exercise in the implementation of social rights by a statutory equality body and a significant step towards the conception of disability rights as universal participation, not just individual or minority group entitlement. The paper considers the distinctive features of that regulatory activity. It asks what sort of equality the DRC set out to achieve for disabled people and where, as a result, its work positioned it on the regulatory spectrum. From the particular experience of the DRC, the paper looks forward to considerations of general relevance to other such bodies, including the new Equality and Human Rights Commission.     

Is it a foundation?

Jersey is the most recent jurisdiction to have prepared a comprehensivedraft of foundation legislation and, subject to completion ofthe legislative process, the law may well be approved this year.This article deals with the legal challenges faced when a commonlaw jurisdiction attempts to incorporate a traditional civillaw entity into a suitable common law format.     

Casting light on excluded subject-matter: recent changes in the UK Patent Office approach to patentable inventions

Following two recent decisions from the High Court, the UK PatentOffice has changed the way it assesses whether or not an inventionis excluded from patent protection by Section 1(2) of the UKPatents Act; this will be of major significance for applicationsfiled in the UK, and particularly for those which concern computer-implementedinventions or business methods.     

The Role of Postmortem Cardiac Markers in the Diagnosis of Acute Myocardial Infarction*

Abstract: Sudden cardiac deaths because of acute myocardial infarction (MI) constitute a significant percentage of the caseload for death investigators, coroners, and forensic pathologists. Clinicians use cardiac markers, highly sensitive and specific for myocardial damage, to screen living patients for acute MI; however, to this point, the utility of these markers in the autopsy setting has not been fully established. The current study included 10 decedents, five who died of acute MI, and five subjects who died of noncardiac disease. Samples of pericardial fluid and blood from multiple sites were tested for creatine kinase, creatinine kinase MB, and troponin‐I. Three main conclusions were drawn: the levels of cardiac markers from all patients are significantly higher than the reference range for living patients, there are significant differences in cardiac marker levels between samples from different anatomic locations, and only three cardiac marker/anatomic site combinations were significantly different between the control and study groups.